Clinically undetected plasmacytoid urothelial carcinoma of the urinary bladder with non-mass-forming metastases in multiple organs: an autopsy case

被引:2
作者
Asano, Yuya [1 ,2 ]
Miyai, Kosuke [2 ,3 ]
Yoshimatsu, Shinya [4 ]
Sasaki, Makoto [5 ]
Ikewaki, Katsunori [5 ]
Matsukuma, Susumu [2 ,4 ]
机构
[1] Natl Def Med Coll, Saitama, Japan
[2] Natl Def Med Coll, Dept Pathol & Lab Med, Saitama, Japan
[3] Japan Self Def Forces Cent Hosp, Dept Pathol, 1-2-24 Ikejiri,Setagaya ku, Tokyo 1548532, Japan
[4] Natl Def Med Coll Hosp, Dept Lab Med, Saitama, Japan
[5] Natl Def Med Coll, Dept Anti Aging & Vasc Med, Saitama, Japan
关键词
Urothelial carcinoma; Plasmacytoid variant; Urinary bladder; Autopsy; Cancer of unknown primary; TRANSITIONAL-CELL-CARCINOMA; CANCER;
D O I
10.4132/jptm.2022.03.15
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This case report outlines a clinically undetected urinary bladder plasmacytoid urothelial carcinoma (PUC) with multiple metastases detected at autopsy. An 89-year-old man presented with edema in the lower limbs. Pleural fluid cytology revealed discohesive carcinomatous cells, although imaging studies failed to identify the primary site of tumor. The patient died of respiratory failure. Autopsy disclosed a prostate tumor and diffusely thickened urinary bladder and rectum without distinct tumorous lesions. Histologically, the tumor consisted of acinar-type prostate adenocarcinoma with no signs of metastasis. Additionally, small, plasmacytoid tumor cells were observed in the urinary bladder/rectum as isolated or small clustering fashions. These metastasized to the lungs, intestine, generalized lymph nodes in a non-mass-forming manner. Combined with immunohistochemical studies, these tumor cells were diagnosed PUC derived from the urinary bladder. Both clinicians and pathologists should recognize PUC as an aggressive histological variant, which can represent a rapid systemic progression without mass-forming lesions.
引用
收藏
页码:217 / 224
页数:8
相关论文
共 20 条
  • [1] Duodenal and rectal obstructions due to urothelial cancer infiltration from recurrent renal pelvic cancer in the bladder wall: An autopsy case
    Ando, Takashi
    Watanabe, Kazuhiro
    Takahashi, Kazuya
    Mizusawa, Takaki
    Sakai, Takeshi
    Katagiri, Akiyoshi
    [J]. UROLOGY CASE REPORTS, 2019, 27
  • [2] Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation
    Chung, Andrew D.
    Schieda, Nicola
    Flood, Trevor A.
    Cagiannos, Ilias
    Mai, Kien T.
    Malone, Shawn
    Morash, Christopher
    Hakim, Shaheed W.
    Breau, Rodney H.
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2017, 11 (1-2): : E50 - E57
  • [3] Outcomes Following Radical Cystectomy for Plasmacytoid Urothelial Carcinoma: Defining the Need for Improved Local Cancer Control
    Cockerill, Patrick A.
    Cheville, John C.
    Boorjian, Stephen A.
    Blackburne, Andrew
    Thapa, Prabin
    Tarrell, Robert F.
    Frank, Igor
    [J]. UROLOGY, 2017, 102 : 143 - 147
  • [4] Plasmacytoid Urothelial Carcinoma, a Chemosensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis
    Dayyani, Farshid
    Czerniak, Bogdan A.
    Sircar, Kanishka
    Munsell, Mark F.
    Millikan, Randall E.
    Dinney, Colin P.
    Siefker-Radtke, Arlene O.
    [J]. JOURNAL OF UROLOGY, 2013, 189 (05) : 1656 - 1660
  • [5] A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
    Kamoun, Aurelie
    de Reynies, Aurelien
    Allory, Yves
    Sjodahl, Gottfrid
    Robertson, A. Gordon
    Seiler, Roland
    Hoadley, Katherine A.
    Groeneveld, Clarice S.
    Al-Ahmadie, Hikmat
    Choi, Woonyoung
    Castro, Mauro A. A.
    Fontugne, Jacqueline
    Eriksson, Pontus
    Mo, Qianxing
    Kardos, Jordan
    Zlotta, Alexandre
    Hartmann, Arndt
    Dinney, Colin P.
    Bellmunt, Joaquim
    Powles, Thomas
    Malats, Nuria
    Chan, Keith S.
    Kim, William Y.
    McConkey, David J.
    Black, Peter C.
    Dyrskjot, Lars
    Hoglund, Mattias
    Lerner, Seth P.
    Real, Francisco X.
    Radvanyi, Francois
    [J]. EUROPEAN UROLOGY, 2020, 77 (04) : 420 - 433
  • [6] Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-Analysis of Clinicopathological Features and Survival Outcomes
    Kim, Do Kyung
    Kim, Jong Won
    Ro, Jae Y.
    Lee, Hye Sun
    Park, Ju-Young
    Ahn, Hyun Kyu
    Lee, Joo Yong
    Cho, Kang Su
    [J]. JOURNAL OF UROLOGY, 2020, 204 (02) : 215 - 223
  • [7] Kohada Yuki, 2020, IJU Case Rep, V3, P166, DOI 10.1002/iju5.12167
  • [8] Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients
    Lae, M.
    Couturier, J.
    Oudard, S.
    Radvanyi, F.
    Beuzeboc, P.
    Vieillefond, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (04) : 815 - 819
  • [9] The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy
    Li, Qiang
    Assel, Melissa
    Benfante, Nicole E.
    Pietzak, Eugene J.
    Herr, Harry W.
    Donat, Machele
    Cha, Eugene K.
    Donahue, Timothy F.
    Bochner, Bernard H.
    Dalbagni, Guido
    [J]. EUROPEAN UROLOGY FOCUS, 2019, 5 (01): : 104 - 108
  • [10] Plasmacytoid urothelial carcinoma of the bladder
    Lopez-Beltran, Antonio
    Requena, Maria J.
    Montironi, Rodolfo
    Blanca, Ana
    Cheng, Liang
    [J]. HUMAN PATHOLOGY, 2009, 40 (07) : 1023 - 1028